"Recently, a CCR5 blocking monoclonal antibody, Le
Post# of 148264
(Total Views: 606)
Posted On: 12/06/2021 8:26:54 AM
"Recently, a CCR5 blocking monoclonal antibody, Leronlimab, has shown exceptional safety, tolerability, and anti-HIV activity in multiple clinical trials."
A federal agency making a positive comment about the safety and tolerability of Leronlimab is a huge step in the right direction. The fact that this award comes from Fauci's department leaves me with mixed feelings. I'm happy for the grant and opportunity. I am suspicious of the guy that runs the department. If Fauci is not working against us, it is a blessing. Still, he doesn't do anything without benefit to himself.
Read More: https://investorshangout.com/post/view?id=629...z7EGxQsinH
A federal agency making a positive comment about the safety and tolerability of Leronlimab is a huge step in the right direction. The fact that this award comes from Fauci's department leaves me with mixed feelings. I'm happy for the grant and opportunity. I am suspicious of the guy that runs the department. If Fauci is not working against us, it is a blessing. Still, he doesn't do anything without benefit to himself.
Read More: https://investorshangout.com/post/view?id=629...z7EGxQsinH
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼